WAT
47
5
LB
34
8
PNW
66
3
EXC
54
-2
SCHW
64
2
APA
21
2
AIV
68
-4
MRO
55
3
AFL
46
-3
FRT
39
-2
F
43
-8
EXR
57
-2
MKC
56
8
JNJ
41
2
CAH
47
3
XYL
37
2
IR
63
3
A
36
2
XOM
47
5
AIG
38
-4
WAT
47
5
LB
34
8
PNW
66
3
EXC
54
-2
SCHW
64
2
APA
21
2
AIV
68
-4
MRO
55
3
AFL
46
-3
FRT
39
-2
F
43
-8
EXR
57
-2
MKC
56
8
JNJ
41
2
CAH
47
3
XYL
37
2
IR
63
3
A
36
2
XOM
47
5
AIG
38
-4
Financhill
Back

NeuroOne Medical Technologies 10K Form

Sell
30

NMTC
NeuroOne Medical Technologies

Last Price:
0.70
Seasonality Move:
166.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-12 10K NMTC/NeuroOne Medical Technologies Annual
2021-01-28 10K NMTC/NeuroOne Medical Technologies Annual
2020-12-09 10K NMTC/NeuroOne Medical Technologies Annual
2020-08-13 10Q NMTC/NeuroOne Medical Technologies Quarterly
2020-05-14 10Q NMTC/NeuroOne Medical Technologies Quarterly
2020-02-14 10Q NMTC/NeuroOne Medical Technologies Quarterly

Receive NMTC News And Ratings

See the #1 stock for the next 7 days that we like better than NMTC

NMTC Financial Statistics

Sales & Book Value

Annual Sales: $1.95M
Cash Flow: $-2.38M
Price / Cash Flow: 0
Annual Sales: $0.11
Price / Book: 7.16

Profitability

EPS (TTM): -0.48000
Net Income (TTM): $-12.1M
Gross Margin: $456.52K
Return on Equity: -282.05%
Return on Assets: -201.81%

NeuroOne Medical Technologies Earnings Forecast

Key NeuroOne Medical Technologies Financial Ratios

  • The Gross Profit Margin over the past 8 years for NMTC is 23.38%.
  • The Selling, General & Administrative Expenses for NMTC have been equal to 354.75% of Gross Profit Margin.
  • The Research & Development expenses have been 355.49% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of NMTC is -607.42% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 5 years.

NeuroOne Medical Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: NMTC
Website: n1mtc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.42
Quick Ratio: 1.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NMTC Technical Analysis vs Fundamental Analysis

Sell
30
NeuroOne Medical Technologies (NMTC) is a Sell

Is NeuroOne Medical Technologies a Buy or a Sell?